Cargando…

Waning sexual function--the most important disease-specific distress for patients with prostate cancer.

The objective was to investigate how prostate cancer and its treatment affects sexual, urinary and bowel functions and to what extent eventual complications cause distress. A questionnaire was sent to 431 men aged 50-80 years with prostate cancer diagnosed in 1992 in the Stockholm area (Sweden) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Helgason, A. R., Adolfsson, J., Dickman, P., Fredrikson, M., Arver, S., Steineck, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074472/
https://www.ncbi.nlm.nih.gov/pubmed/8645589
_version_ 1782137974093250560
author Helgason, A. R.
Adolfsson, J.
Dickman, P.
Fredrikson, M.
Arver, S.
Steineck, G.
author_facet Helgason, A. R.
Adolfsson, J.
Dickman, P.
Fredrikson, M.
Arver, S.
Steineck, G.
author_sort Helgason, A. R.
collection PubMed
description The objective was to investigate how prostate cancer and its treatment affects sexual, urinary and bowel functions and to what extent eventual complications cause distress. A questionnaire was sent to 431 men aged 50-80 years with prostate cancer diagnosed in 1992 in the Stockholm area (Sweden) and 435 randomly selected men with a similar age distribution. Sexual function, as compared with their youth, was diminished in a majority of all men. The prostate cancer patients were, however, more likely to report low frequency and/or intensity in all aspects of sexual function. A majority of the men were distressed by a waning sexual capacity. The proportion of men with prostate cancer who were severely distressed owing to a decline in sexual function was larger than in the reference group. The willingness to trade off an intact sexual function for long-term survival varied considerably among the men in the reference group. Urinary and bowel symptoms were less common than a waning sexual function in both groups, and few appeared to be severely distressed by urinary or bowel symptoms. A decline in sexual functions was the most common cause of disease-specific distress in men with prostate cancer.
format Text
id pubmed-2074472
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20744722009-09-10 Waning sexual function--the most important disease-specific distress for patients with prostate cancer. Helgason, A. R. Adolfsson, J. Dickman, P. Fredrikson, M. Arver, S. Steineck, G. Br J Cancer Research Article The objective was to investigate how prostate cancer and its treatment affects sexual, urinary and bowel functions and to what extent eventual complications cause distress. A questionnaire was sent to 431 men aged 50-80 years with prostate cancer diagnosed in 1992 in the Stockholm area (Sweden) and 435 randomly selected men with a similar age distribution. Sexual function, as compared with their youth, was diminished in a majority of all men. The prostate cancer patients were, however, more likely to report low frequency and/or intensity in all aspects of sexual function. A majority of the men were distressed by a waning sexual capacity. The proportion of men with prostate cancer who were severely distressed owing to a decline in sexual function was larger than in the reference group. The willingness to trade off an intact sexual function for long-term survival varied considerably among the men in the reference group. Urinary and bowel symptoms were less common than a waning sexual function in both groups, and few appeared to be severely distressed by urinary or bowel symptoms. A decline in sexual functions was the most common cause of disease-specific distress in men with prostate cancer. Nature Publishing Group 1996-06 /pmc/articles/PMC2074472/ /pubmed/8645589 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Helgason, A. R.
Adolfsson, J.
Dickman, P.
Fredrikson, M.
Arver, S.
Steineck, G.
Waning sexual function--the most important disease-specific distress for patients with prostate cancer.
title Waning sexual function--the most important disease-specific distress for patients with prostate cancer.
title_full Waning sexual function--the most important disease-specific distress for patients with prostate cancer.
title_fullStr Waning sexual function--the most important disease-specific distress for patients with prostate cancer.
title_full_unstemmed Waning sexual function--the most important disease-specific distress for patients with prostate cancer.
title_short Waning sexual function--the most important disease-specific distress for patients with prostate cancer.
title_sort waning sexual function--the most important disease-specific distress for patients with prostate cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074472/
https://www.ncbi.nlm.nih.gov/pubmed/8645589
work_keys_str_mv AT helgasonar waningsexualfunctionthemostimportantdiseasespecificdistressforpatientswithprostatecancer
AT adolfssonj waningsexualfunctionthemostimportantdiseasespecificdistressforpatientswithprostatecancer
AT dickmanp waningsexualfunctionthemostimportantdiseasespecificdistressforpatientswithprostatecancer
AT fredriksonm waningsexualfunctionthemostimportantdiseasespecificdistressforpatientswithprostatecancer
AT arvers waningsexualfunctionthemostimportantdiseasespecificdistressforpatientswithprostatecancer
AT steineckg waningsexualfunctionthemostimportantdiseasespecificdistressforpatientswithprostatecancer